Company Hosts Cell Therapy Summit to Discuss Best Practices for Bringing Therapeutics to Market

CARLSBAD, Calif.–Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative life science solutions, today is hosting the 1st Annual Cell Therapy Industry Summit, gathering leaders from all areas of cell therapy to discuss best practices and opportunities for bringing potential life saving therapeutics to market. Participants hail from companies, academic institutions and the California Institute of Regenerative Medicine (CIRM).

Cell therapies are medical treatments wherein new cells are introduced into a patient to fight disease. Many of these therapies are based on stem cells, which are cells within the body that can differentiate into a range of specialized cell types. Scientists believe that therapies based on stem cells hold the promise to treat a wide range of debilitating conditions, including diabetes, Alzheimer’s and Parkinson’s disease, and spinal cord injuries.

“Successful science relies on the open exchange of ideas that stimulate researchers to pursue new avenues of inquiry,” noted Greg Lucier, Chairman and CEO of Life Technologies. “Life Technologies is focused on shaping discovery, and by bringing together leaders in the regenerative medicine industry, we facilitate that discussion, which can only help push these potential life-altering therapies closer to the clinic and eventual commercialization.”

CIRM and two international partners recently awarded more than $250 million to 14 multidisciplinary teams of researchers in California, the United Kingdom and Canada to develop stem cell-based therapies for 11 diseases. The funding is expected to speed the process of establishing clinical trials.

“This meeting represents the first time that scientists and executives from companies focused on cell therapies have gathered in California to specifically discuss the pace of discovery at companies seeking to realize the promise of cell therapies,” said Alan Trounson, President of the California Institute for Regenerative Medicine. “Recent funding further establishes this state as the epicenter of innovation and these companies are among those whose work holds the greatest promise to ultimately bring innovative cell therapies to market.”

The Cell Therapy Industry Summit provides participants opportunities to learn from panel discussions and to network at various functions. Speakers from companies that are advancing the development of cell therapies will be discussing a wide range of topics including broad trends in the business side of cell therapies, issues critical to making cell therapeutics manufacturing more economical, and technical issues that must be overcome to facilitate the regulatory pathway for new medicines.

In addition to hosting this event in Carlsbad, California, Life Technologies is sponsoring 4th Annual Stem Cells on the Mesa Meeting today in La Jolla, California, which is hosted by the San Diego Consortium for Regenerative Medicine and produced by CONNECT. The Stem Cells on the Mesa Meeting draws together San Diego’s pioneers who are responsible for advancing research towards discovering cures for debilitating diseases or injuries.

About Life Technologies

Life Technologies Corporation (NASDAQ:LIFE) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of more than $3 billion in 2008, employs approximately 9,500 people, has a presence in more than 100 countries, and possesses a rapidly growing intellectual property estate of approximately 3,600 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc. For more information on how we are making a difference please visit our website: www.lifetechnologies.com. Follow Life Technologies on Twitter @LIFECorporation and on Facebook.

Safe Harbor Statement

This press release includes forward-looking statements about our anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies’ plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words “believe,” “plan,” “intend,” “anticipate,” “target,” “estimate,” “expect” and the like, and/or future tense or conditional constructions (“will,” “may,” “could,” “should,” etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.